A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Clinical trial NCT05364944 · TERMINATED
Trial details
- NCT number
- NCT05364944
- Sponsor
- Debiopharm International SA
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2024-10-29
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.